AVE-1330A
99%
- Product Code: 99618
CAS:
1192491-61-4
Molecular Weight: | 287.23 g./mol | Molecular Formula: | C₇H₁₀N₃O₆Na |
---|---|---|---|
EC Number: | MDL Number: | MFCD28900719 | |
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | -20℃ |
Product Description:
AVE-1330A is primarily explored for its potential therapeutic applications, particularly in the field of cardiovascular health. It is investigated as a vasopeptidase inhibitor, which means it targets enzymes involved in blood pressure regulation. By inhibiting these enzymes, it may help manage hypertension and improve heart function. Research suggests its role in reducing vascular resistance and enhancing cardiac output, making it a candidate for treating conditions like heart failure and high blood pressure. Additionally, its dual action on both the renin-angiotensin system and natriuretic peptide pathways could offer broader benefits in cardiovascular disease management. Further studies are ongoing to validate its efficacy and safety in clinical settings.
Product Specification:
Test | Specification |
---|---|
APPEARANCE | White to off-white solid |
PURITY | 98.5-100 |
Infrared spectrum | Conforms to Structure |
Sizes / Availability / Pricing:
Size (g) | Availability | Price | Quantity |
---|---|---|---|
0.005 | 10-20 days | ฿320.00 |
+
-
|
0.025 | 10-20 days | ฿590.00 |
+
-
|
0.100 | 10-20 days | ฿1,780.00 |
+
-
|
0.250 | 10-20 days | ฿2,680.00 |
+
-
|
1.000 | 10-20 days | ฿8,080.00 |
+
-
|
5.000 | 10-20 days | ฿20,500.00 |
+
-
|
AVE-1330A
AVE-1330A is primarily explored for its potential therapeutic applications, particularly in the field of cardiovascular health. It is investigated as a vasopeptidase inhibitor, which means it targets enzymes involved in blood pressure regulation. By inhibiting these enzymes, it may help manage hypertension and improve heart function. Research suggests its role in reducing vascular resistance and enhancing cardiac output, making it a candidate for treating conditions like heart failure and high blood pressure. Additionally, its dual action on both the renin-angiotensin system and natriuretic peptide pathways could offer broader benefits in cardiovascular disease management. Further studies are ongoing to validate its efficacy and safety in clinical settings.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :